VALARIE MITCHELL: Open Payments
NPI 1164448981 · CORINTH, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,189 in 53 payments from 29 companies in 2025. Trend: 2023 $1,228 · 2024 $1,410 · 2025 $1,189
Food & beverage: $1,189
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 8 | $167 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $112 |
| Eisai Inc. | 5 | $92 |
| Adaptive Biotechnologies Corporation | 3 | $92 |
| Novartis Pharmaceuticals Corporation | 3 | $65 |
| AstraZeneca Pharmaceuticals LP | 3 | $59 |
| GlaxoSmithKline, LLC. | 2 | $49 |
| BeOne Medicines USA, Inc. | 2 | $48 |
| Janssen Biotech, Inc. | 2 | $47 |
| GENZYME CORPORATION | 1 | $31 |
Products named: KEYTRUDA, Lenvima, clonoSEQ, ICLUSIG, NINLARO, JEMPERLI, BRUKINSA, LYNPARZA.
Industry payments across MS — which companies pay providers there.
